Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Permian Resources | PR | Jul 26, 2024 | 15.31 | -0.52 |
Permianville Royalty Trust Unit | PVL | Jul 26, 2024 | 1.51 | -2.58 |
PermRock Royalty Trust Unit | PRT | Jul 26, 2024 | 4.03 | +2.03 |
Perpetua Resources | PPTA | Jul 26, 2024 | 6.71 | +5.67 |
Perrigo | PRGO | Jul 26, 2024 | 28.11 | +0.14 |
Personalis | PSNL | Jul 26, 2024 | 3.45 | +20.63 |
Perspective Therapeutics | CATX | Jul 26, 2024 | 13.70 | +0.59 |
Petco Health And Wellness | WOOF | Jul 26, 2024 | 3.54 | +2.91 |
PetIQ A | PETQ | Jul 26, 2024 | 21.89 | +2.05 |
PetMed Express | PETS | Jul 26, 2024 | 4.02 | +2.55 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Jul 26, 2024 | 14.47 | +0.07 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Jul 26, 2024 | 13.31 | +0.15 |
Petros Pharmaceuticals | PTPI | Jul 26, 2024 | 0.42 | -1.39 |
Pfizer | PFE | Jul 26, 2024 | 30.77 | +1.95 |
Pgim Global High Yield Fund | GHY | Jul 26, 2024 | 12.32 | +0.16 |
Pgim High Yield Bond Fund | ISD | Jul 26, 2024 | 13.44 | +0.45 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Jul 26, 2024 | 15.57 | -0.03 |
Pharmaceutical ETF Market Vectors | PPH | Jul 26, 2024 | 93.28 | +0.70 |
PharmaCyte Biotech | PMCB | Jul 26, 2024 | 1.98 | -1.93 |
Pharming Group ADR | PHAR | Jul 26, 2024 | 7.99 | -6.00 |
Pharvaris | PHVS | Jul 26, 2024 | 17.40 | -0.23 |
Phathom Pharmaceuticals | PHAT | Jul 26, 2024 | 11.74 | +4.08 |
PhenixFIN | PFX | Jul 26, 2024 | 47.64 | +0.08 |
Phibro Animal Health A | PAHC | Jul 26, 2024 | 18.88 | +0.27 |
Philip Morris | PM | Jul 26, 2024 | 113.36 | +0.14 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Jul 26, 2024 | 25.40 | +1.52 |
Phillips 66 | PSX | Jul 26, 2024 | 142.21 | -0.21 |
Phillips Edison & Company | PECO | Jul 26, 2024 | 34.02 | +0.50 |
PHINIA | PHIN | Jul 26, 2024 | 44.40 | +3.06 |
Phio Pharmaceuticals | PHIO | Jul 26, 2024 | 3.98 | +3.60 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.